A detailed history of Northwest Investment Counselors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Northwest Investment Counselors, LLC holds 3,645 shares of AMGN stock, worth $1.15 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
3,645
Previous 3,603 1.17%
Holding current value
$1.15 Million
Previous $1.13 Million 4.36%
% of portfolio
0.28%
Previous 0.3%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$309.38 - $337.38 $12,993 - $14,169
42 Added 1.17%
3,645 $1.17 Million
Q1 2024

Apr 12, 2024

BUY
$268.87 - $324.56 $67,217 - $81,140
250 Added 7.46%
3,603 $1.02 Million
Q3 2023

Oct 12, 2023

BUY
$218.65 - $271.46 $1,311 - $1,628
6 Added 0.18%
3,353 $901,000
Q2 2023

Jul 11, 2023

BUY
$214.27 - $253.37 $34,497 - $40,792
161 Added 5.05%
3,347 $743,000
Q4 2022

Jan 18, 2023

BUY
$229.03 - $291.01 $17,177 - $21,825
75 Added 2.41%
3,186 $0
Q2 2022

Jul 26, 2022

SELL
$230.71 - $256.74 $1,845 - $2,053
-8 Reduced 0.26%
3,111 $757,000
Q3 2021

Oct 19, 2021

BUY
$212.27 - $248.7 $7,004 - $8,207
33 Added 1.07%
3,119 $663,000
Q2 2021

Jul 22, 2021

BUY
$233.58 - $259.14 $11,679 - $12,957
50 Added 1.65%
3,086 $752,000
Q4 2020

Jan 26, 2021

SELL
$216.38 - $257.67 $6,058 - $7,214
-28 Reduced 0.91%
3,036 $698,000
Q3 2020

Oct 21, 2020

BUY
$234.65 - $260.95 $23,465 - $26,095
100 Added 3.37%
3,064 $779,000
Q1 2020

Apr 21, 2020

BUY
$182.24 - $241.7 $1,457 - $1,933
8 Added 0.27%
2,964 $601,000
Q4 2018

Jan 28, 2019

BUY
$178.4 - $208.25 $22,835 - $26,656
128 Added 4.53%
2,956 $575,000
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $3,335 - $3,760
-18 Reduced 0.63%
2,828 $586,000
Q3 2017

Oct 30, 2017

BUY
$167.29 - $191.0 $476,107 - $543,586
2,846
2,846 $531,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.